Reporting the capture efficiency of a filter-based microdevice: A CTC is not a CTC unless it is CD45 negative - Letter

Clinical Cancer Research

Volumn 17, Issue 9, 2011, Pages 3048-3049

  Attard, Gerhardt ^a   Crespo, Mateus ^a   Lim, Ai Chiin ^a   Pope, Lorna ^a   Zivi, Andrea ^a   De Bono, Johann S ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

4',6 DIAMIDINO 2 PHENYLINDOLE; CD45 ANTIGEN; CYTOKERATIN;

CLINICAL EFFECTIVENESS; FILTER; FILTER BASED MICRODEVICE; HUMAN; IMMUNOFLUORESCENCE; LETTER; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; PUBLICATION; STANDARD; TUMOR EMBOLISM; VALIDATION PROCESS;

ANTIGENS, CD45; CARCINOMA; CELL SEPARATION; DIAGNOSIS, DIFFERENTIAL; DIAGNOSTIC ERRORS; EFFICIENCY; HUMANS; MALE; MICROFLUIDIC ANALYTICAL TECHNIQUES; MICROPORE FILTERS; MINIATURIZATION; NEOPLASTIC CELLS, CIRCULATING; PROSTATIC NEOPLASMS; RESEARCH DESIGN;

EID: 79955520670     PISSN: 10780432     EISSN: 15573265     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-10-3234     Document Type: Letter

References (6)

1. Lin HK, Zheng S, Williams AJ, Balic M, Groshen S, Scher HI, et al. Portable filter-based microdevice for detection and characterization of circulating tumor cells. Clin Cancer Res 2010;16:5011-8.
2. Meng S, Tripathy D, Frenkel EP, Shete S, Naftalis EZ, Huth JF, et al. Circulating tumor cells in patients with breast cancer dormancy. Clin Cancer Res 2004;10:8152-62. (Pubitemid 40053373)
3. Allard WJ, Matera J, Miller MC, Repollet M, Connelly MC, Rao C, et al. Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases. Clin Cancer Res 2004;10:6897-904. (Pubitemid 39383039)
4. Riethdorf S, Fritsche H, M€uller V, Rau T, Schindlbeck C, Rack B, et al. Detection of circulating tumor cells in peripheral blood of patients with metastatic breast cancer: a validation study of the CellSearch system. Clin Cancer Res 2007;13:920-8. (Pubitemid 46340368)
5. Attard G, Swennenhuis JF, Olmos D, Reid AHM, Vickers E, A'Hern R, et al. Characterization of ERG, AR and PTEN gene status in circulating tumor cells from patients with castration-resistant prostate cancer. Cancer Res 2009;69:2912-8.
6. - objects predict overall survival in castration-resistant prostate cancer. Ann Oncol 2010;21: 1851-7.